Clinical Trial Update: Headache Study to Compare Aggrenox Full Dose and Reduced Dose [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing full-dose versus reduced-dose Aggrenox in patients with a cerebrovascular accident has completed. The study assesses whether a lower d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Aggrenox (aspirin and dipyridamole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Cerebrovascular Accident | Phase 3 | Status: COMPLETED